WELLSTAR gives WELL Health a big advantage, this analyst says

Stifel analyst Justin Keywood says WELL Health Technologies’ (WELL Health Technologies  Stock Quote, Chart, News, Analysts, Financials TSX:WELL) majority-owned WELLSTAR platform gives the company a strategic advantage as it builds out its Canadian healthcare consolidation model.

In a June 22 conference recap following Stifel’s Summer Solstice Conference, the analyst said WELLSTAR is a fast-growing healthcare software platform that helps make clinics more efficient while connecting fragmented parts of the Canadian health system.

WELL owns about 72% of WELLSTAR, which is expected to be spun out as an independent company. That move was one of the goals outlined in WELL’s 2026 CEO shareholder letter.

Keywood noted that WELLSTAR has completed 23 transactions and raised $112-million privately. The platform continues to target Canadian healthcare technology assets that can be integrated and cross-sold across the broader system.

At the clinic level, WELLSTAR’s AI Scribe tools reduce administrative work for practitioners, while OceanMD helps move referrals away from fax-based processes. Stifel said about 85% of Canadian referrals are still handled by fax, leaving a large opportunity for OceanMD and other WELLSTAR tools.

The analyst said the platform is growing organically at about 20%, helped by demand for technologies that improve physician productivity and system efficiency. Management also sees room to add more tools through acquisitions, with three dedicated business development professionals focused on the pipeline.

Keywood said WELL’s clinic network gives WELLSTAR a major advantage. WELL has the largest clinic footprint in Canada, with 252 clinics, giving WELLSTAR a testing ground for new technologies and a data pool for assessing tools before selling them more broadly.

The analyst said that network should help WELLSTAR commercialize products, evaluate acquisition targets and strengthen WELL’s broader healthcare rollup strategy.

“The strategic value could compound as WELL continues its own M&A pursuits in rolling up Canadian healthcare assets,” Stifel said.

Keywood said WELL was one of its preferred names coming out of the conference because of its technology that empowers health clinics and improves system efficiency.

Disclosure: Nick Waddell owns shares of WELL Health and the company is a sponsor of Cantech Letter.

-30-